{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T23:51:55Z","timestamp":1769039515945,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.3816\/clm.2000.s.008","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T21:01:57Z","timestamp":1221166917000},"page":"S41-S44","source":"Crossref","is-referenced-by-count":23,"special_numbering":"S1","title":["Historical Perspective on the Use of Retinoids in Cutaneous T-Cell Lymphoma(CTCL)"],"prefix":"10.3816","volume":"1","author":[{"given":"G\u00fcnter","family":"Burg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2000.s.008_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1040-0486(97)80009-9","article-title":"Cutaneous lymphomas","volume":"9","author":"Burg","year":"1997","journal-title":"Curr Probl Dermatol"},{"key":"10.3816\/CLM.2000.s.008_bib2","series-title":"Cutaneous Lymphomas, Pseudolymphomas, and Related Disorders","author":"Burg","year":"1983"},{"key":"10.3816\/CLM.2000.s.008_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0560.1995.tb00733.x","article-title":"Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates","volume":"22","author":"Dummer","year":"1995","journal-title":"J Cutan Pathol"},{"key":"10.3816\/CLM.2000.s.008_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archderm.1969.01610220097017","article-title":"Topical vitamin A acid in acne vulgaris","volume":"99","author":"Kligman","year":"1969","journal-title":"Arch Dermatol"},{"issue":"suppl 1","key":"10.3816\/CLM.2000.s.008_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.1991.tb08129.x","article-title":"Retinoids and interferon: a new promising combination?","volume":"79","author":"Bollag","year":"1991","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2000.s.008_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0277-5379(91)90061-H","article-title":"Potentiation of retinoid-induced differentiation of HL-60 and U937 cell lines by cytokines","volume":"27","author":"Peck","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.3816\/CLM.2000.s.008_bib7","first-page":"1071","article-title":"Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas","volume":"8","author":"Sundaresan","year":"1997","journal-title":"Cell Growth Differ"},{"key":"10.3816\/CLM.2000.s.008_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0145-2126(98)00049-6","article-title":"Retinoic acids induce growth inhibition and apoptosis in adult T-cell leukemia (ATL) cell lines","volume":"22","author":"Fujimura","year":"1998","journal-title":"Leuk Res"},{"key":"10.3816\/CLM.2000.s.008_bib9","first-page":"525","article-title":"Factors associated with the therapeutic efficacy of retinoic acids on malignant lymphomas","volume":"96","author":"Cheng","year":"1997","journal-title":"J Formos Med Assoc"},{"key":"10.3816\/CLM.2000.s.008_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/1523-1747.ep12413014","article-title":"Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation","volume":"103","author":"Meunier","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2000.s.008_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1749-6632.1996.tb52680.x","article-title":"The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma","volume":"795","author":"Rook","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.3816\/CLM.2000.s.008_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells","volume":"99","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2000.s.008_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archderm.1993.01680250045005","article-title":"Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation","volume":"129","author":"Dummer","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2000.s.008_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2165\/00003495-199753030-00003","article-title":"Current use and future potential role of retinoids in dermatology","volume":"53","author":"Orfanos","year":"1997","journal-title":"Drugs"},{"key":"10.3816\/CLM.2000.s.008_bib15","series-title":"Retinoids in Cutaneous Malignancy","author":"Marks","year":"1991"},{"key":"10.3816\/CLM.2000.s.008_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/oxfordjournals.annonc.a058252","article-title":"Retinoids in cancer prevention and therapy","volume":"3","author":"Bollag","year":"1992","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2000.s.008_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia","volume":"72","author":"Huang","year":"1988","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.s.008_bib18","first-page":"106","article-title":"All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi)","volume":"82","author":"Sacchi","year":"1997","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2000.s.008_bib19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0889-8588(18)30063-7","article-title":"Experimental therapies in the treatment of cutaneous T-cell lymphoma","volume":"9","author":"Foss","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.3816\/CLM.2000.s.008_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0733-8635(18)30191-8","article-title":"Therapeutic approaches in cutaneous lymphoma","volume":"12","author":"Jorg","year":"1994","journal-title":"Dermatol Clin"},{"key":"10.3816\/CLM.2000.s.008_bib21","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(83)92136-0","article-title":"Treatment of cutaneous Tcell lymphoma (mycosis fungoides) with 13-cis-retinoic acid","volume":"1","author":"Kessler","year":"1983","journal-title":"Lancet"},{"key":"10.3816\/CLM.2000.s.008_bib22","first-page":"232","article-title":"Oral retinoids in mycosis fungoides and Sezary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides Group","volume":"67","author":"Molin","year":"1987","journal-title":"Acta Derm Venereol"},{"key":"10.3816\/CLM.2000.s.008_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0190-9622(91)70036-2","article-title":"Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids","volume":"24","author":"Knobler","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2000.s.008_bib24","first-page":"387","article-title":"Use of isotretinoin and etretinate for the treatment of benign cutaneous neoplasia and cutaneous lymphoma in dogs","volume":"202","author":"White","year":"1993","journal-title":"J Am Vet Med Assoc"},{"key":"10.3816\/CLM.2000.s.008_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2133.1983.tb03991.x","article-title":"Treatment of cutaneous lymphoma with etretinate","volume":"109","author":"Claudy","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.3816\/CLM.2000.s.008_bib26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2133.1988.tb02600.x","article-title":"Treatment of mycosis fungoides with recombinant interferon-alpha 2a2 alone and in combination with etretinate","volume":"118","author":"Thestrup-Pedersen","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.3816\/CLM.2000.s.008_bib27","first-page":"3578","article-title":"Prospective randomized multicenter clinical trial on the use of interferon-2a plus acitretin versus interferon-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II","volume":"92","author":"Stadler","year":"1998","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.s.008_bib28","first-page":"200","article-title":"Eindrucksvolle remission einer mycosis fungoides im tumorstadium unter low-dose interferon und acitretin nach erfolgloser chemotherapie","volume":"70","author":"Bauch","year":"1995","journal-title":"Z Hautkr"},{"key":"10.3816\/CLM.2000.s.008_bib29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.1997.15.2.790","article-title":"Initial clinical trial of a selective retinoid X receptor ligand, LGD1069","volume":"15","author":"Miller","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.s.008_bib30","unstructured":"Harms M. Systemisches Isotretinoin. Roche Editiones, 1994."},{"key":"10.3816\/CLM.2000.s.008_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archderm.1987.01660260071016","article-title":"Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides)","volume":"123","author":"Kessler","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2000.s.008_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archinte.1987.00370030133026","article-title":"The effect of isotretinoin in six patients with cutaneous T-cell lymphoma","volume":"147","author":"Neely","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.3816\/CLM.2000.s.008_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00509025","article-title":"Treatment of cutaneous T-cell lymphoma with a new aromatic retinoid (Ro 10-9359)","volume":"273","author":"Claudy","year":"1982","journal-title":"Arch Dermatol Res"},{"key":"10.3816\/CLM.2000.s.008_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(87)80055-5","article-title":"Treatment of cutaneous T-cell lymphoma with the arotinoid Ro 13-6298","volume":"16","author":"Tousignant","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2000.s.008_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1440-0960.1984.tb00631.x","article-title":"A case of mycosis fungoides treated with etretinate","volume":"25","author":"Wargon","year":"1984","journal-title":"Australas J Dermatol"},{"key":"10.3816\/CLM.2000.s.008_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/stem.5530110403","article-title":"Roferon-A (interferon alpha 2a) combined with Tigason (etretinate) for treatment of cutaneous T cell lymphomas","volume":"11","author":"Dreno","year":"1993","journal-title":"Stem Cells"},{"key":"10.3816\/CLM.2000.s.008_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-4362.1993.tb01458.x","article-title":"Intramuscular low dose alpha-2B interferon and etretinate for treatment of mycosis fungoides","volume":"32","author":"Altomare","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.3816\/CLM.2000.s.008_bib38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1346-8138.1994.tb03285.x","article-title":"Interferon-alpha (INF-alpha) and etretinate in the treatment of mycosis fungoides","volume":"21","author":"Torii","year":"1994","journal-title":"J Dermatol"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511702779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511702779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T02:41:54Z","timestamp":1588905714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526965511702779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":38,"alternative-id":["S1526965511702779"],"URL":"https:\/\/doi.org\/10.3816\/clm.2000.s.008","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}